Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 11-14 September 2023
Agenda of the HMPC meeting 18-20 September 2023
Opinion/decision on a Paediatric investigation plan (PIP): Etrasimod L-arginine, decision type: , therapeutic area: , PIP number: P/0409/2022
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, Amsterdam, from 28/06/2023 to 28/06/2023
10th anniversary of European Medicines Agency (EMA) Healthcare Professionals' (HCPWP) Working Party meeting, Amsterdam, from 27/06/2023 to 27/06/2023
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) Working Party meeting, Amsterdam, from 27/06/2023 to 27/06/2023
Opinion/decision on a Paediatric investigation plan (PIP): sotatercept, decision type: , therapeutic area: , PIP number: P/0414/2022
Opinion/decision on a Paediatric investigation plan (PIP): Adrenaline (epinephrine), decision type: , therapeutic area: , PIP number: P/0404/2022
Opinion/decision on a Paediatric investigation plan (PIP): Monalizumab, decision type: , therapeutic area: , PIP number: P/0405/2022
Opinion/decision on a Paediatric investigation plan (PIP): Plasma kallikrein inhibitor, decision type: , therapeutic area: , PIP number: P/0379/2022